ISRCTN07452238
Completed
N/A
A study to determine the cardiovascular effects of different methods of administering the oxytocic drug Syntocino
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 sites30 target enrollmentSeptember 12, 2003
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women choosing spinal anaesthesia for elective Caesarean:
- •15 in control group receiving syntocinon 5 units intravenously (IV) as a bolus after delivery 15 in study group receiving syntocinon 5 units IV continuously over 5 min after delivery
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesEUCTR2015-003563-10-ROovo Nordisk A/S3,183
Active, Not Recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesEUCTR2015-003563-10-ITOVO NORDISK. S.P.A.3,183
Active, Not Recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesEUCTR2015-003563-10-GBovo Nordisk A/S3,183
Active, Not Recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesEUCTR2015-003563-10-NLovo Nordisk A/S3,176
Active, Not Recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2MedDRA version: 19.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2015-003563-10-ESovo Nordisk A/S3,176